OPTINEX Trademark

Trademark Overview

On Friday, January 28, 2011, a trademark application was filed for OPTINEX with the United States Patent and Trademark Office. The USPTO has given the OPTINEX trademark a serial number of 85228435. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Glaxo Group Limited. The OPTINEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
optinex

General Information

Serial Number85228435
Word MarkOPTINEX
Filing DateFriday, January 28, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2019EXTENSION 5 GRANTED
Wednesday, October 16, 2019EXTENSION 5 FILED
Monday, October 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 16, 2019TEAS EXTENSION RECEIVED
Friday, April 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2019EXTENSION 4 GRANTED
Wednesday, April 17, 2019EXTENSION 4 FILED
Wednesday, April 17, 2019TEAS EXTENSION RECEIVED
Friday, October 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 3, 2018EXTENSION 3 GRANTED
Wednesday, October 3, 2018EXTENSION 3 FILED
Wednesday, October 3, 2018TEAS EXTENSION RECEIVED
Thursday, April 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 17, 2018EXTENSION 2 GRANTED
Tuesday, April 17, 2018EXTENSION 2 FILED
Tuesday, April 17, 2018TEAS EXTENSION RECEIVED
Friday, September 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2017EXTENSION 1 GRANTED
Wednesday, September 27, 2017EXTENSION 1 FILED
Wednesday, September 27, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 26, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 13, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, June 13, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 7, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 1, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 1, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 19, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 15, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 6, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 31, 2012REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 30, 2012REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 25, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 25, 2011ASSIGNED TO LIE
Monday, April 25, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 25, 2011LETTER OF SUSPENSION E-MAILED
Monday, April 25, 2011SUSPENSION LETTER WRITTEN
Friday, April 22, 2011ASSIGNED TO EXAMINER
Tuesday, February 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 1, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

optinex pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological